Stock.Editas Medicine EDITStockUSD1.210.021.63% Editas Medicine pattern recognition tool provides the execution environment for running the Counterattack recognition and other technical functions against Editas Medicine. Editas Medicine value trend is the prevailing direction of the price over some defined pe...
Editas’ Cas9 patentalso has MIT and The Rockefeller University listed as co-owners. The deal news sentVertex’s stock priceup by more than 9% on Wednesday, whileEditasonly saw a stock increase of over 2%. Separately from the licensing agreement, Editas itself has a CRISPR-based therapyin...
Editas has issued more than 4 million shares of unvested restricted stock as of November 30, 2015, at an average exercise price of $2.50 per share. Anyone